CKB News Archive



  • 2020
    • February
      • Check out this recent article to learn how CKB can be your genomic digital encyclopedia of cancer! Mainstreaming Precision Oncology
      • The JAX-CKB team is looking for a Variant Assay Interpretation Scientist! More details regarding this exciting position can be found here.
  • 2020
    • January
      • CKB CORE now offers content for RSPO3, POLE, FANCA, and DOT1L, but removes EGFR, PTEN, TP53, and MET. However, these genes are always accessible with a CKB BOOST subscription!
      • We're looking for new people to join the JAX-CKB team! Check out the job listings here: Scientific Software Engineer
  • 2019
    • October
      • Have a question about CKB or want to learn more about it? Then check out The Scoop on CKB!
  • 2019
    • July
      • CKB BOOST now has AMP/CAP/ASCO evidence level coding!
  • 2018
    • November
      • Vitrakvi (larotrectinib) approved regardless of tumor type for NTRK fusions, except with acquired resistance mutations! Need a list of resistance mutations? Visit ckbhome.jax.org and sign-up for CKB BOOST.
  • 2017
    • October
      • Barriers preventing the adoption of comprehensive cancer genomic profiling in the clinic (PMID: 28402162). Limited free copies available; request your copy at ckbsupport@jax.org.